Your trusted destination for CME, CPD & Medical Education across the Middle East.
A 2-day advanced conference and certification program in Dubai focusing on the clinical integration of cellular therapies, exosomes, and peptides.
The ISSCA Cellular Therapies & Regenerative Medicine Certification (UAE Edition) will take place on December 4–5, 2026, at the Hyatt Regency Dubai Creek Heights in Dubai, United Arab Emirates. Organized by the International Society for Stem Cell Application (ISSCA)—a global pioneer in regenerative medical education operating across more than 45 countries with over 12,000 trained physicians—this two-day intensive congress and hands-on masterclass serves as an advanced certification platform for licensed medical doctors, specialist surgeons, orthopedic specialists, dermatologists, sports medicine physicians, and clinical researchers across the Middle East and international healthcare communities. Structured around an integrated dual-level educational framework, the program combines an all-encompassing international plenary conference on Day 1 with dedicated, small-group physician certification tracks on Day 2. The scientific curriculum bridges fundamental cellular biology with real-world bedside execution, focusing on the clinical integration of the core triad of modern regenerative medicine: mesenchymal stem cells (MSCs), secretomes/exosomes, and therapeutic peptides. Day 1 features comprehensive plenary keynotes and breakout modules covering over 200 validated clinical protocols across five primary clinical verticals: * Orthopedics & Sports Medicine: Joint repair, acute/chronic tendinopathy, cartilage regeneration, and accelerated return-to-sport protocols. * Advanced Regenerative Aesthetics: Exosome-driven facial rejuvenation, GHK-Cu peptide stacks, hair restoration, and post-laser skin remodeling. * Immunology, Autoimmunity & Longevity: Inflammaging, macrophage reprogramming (M1 to M2 phenotype shift), NK cell immune rejuvenation, senolytics, telomere maintenance, and mitochondrial optimization. * Gyneco-Regenerative & Sexual Health: Perimenopausal wellness, tissue revitalization, and functional sexual health protocols. * Applied Peptide Medicine & Neuro-Regeneration: Clinical stack architecture using GH-axis secretagogues (Tesamorelin, Ipamorelin), tissue repair agents (BPC-157, TB-500), neuro-protective compounds (Selank, Dihexa, Cerebrolysin), and immunomodulators (Thymosin Alpha-1). The program highlights the practical synergy between cellular therapies, hyperbaric oxygen therapy (HBOT), pulsed electromagnetic field (PEMF) therapy, and artificial intelligence tools for functional diagnostics and real-time treatment response tracking. On Day 2, delegates enter exclusive hands-on certification modules—choosing between Track A (Cellular Therapies) or Track B (Advanced Peptide Therapy). In these tracks, clinicians analyze real patient cases, review cell harvesting and bio-availability dynamics, master ultrasound-guided delivery techniques, and learn how to construct personalized, phase-based care plans. Beyond procedural mastery, the ISSCA UAE summit emphasizes strict national regulatory alignment, medical-legal safety frameworks, and practical clinic implementation. Attending physicians leave with ready-to-use clinical consent forms, standardized post-procedure protocols, case-study reference guides, and administrative workflows designed for immediate clinical implementation. Upon completing the full two-day program, licensed participants are awarded the official, internationally recognized ISSCA Certification credential, granting priority access to the ISSCA mobile application, updated protocol databases, exclusive MedConnect networking channels, and a global professional network of certified regenerative medicine practitioners.
Mechanisms and clinical integration of MSCs, Muse Cells, NK Cells, and Exosomes.
Indications, dosing, administration routes, and safety standards for cell-based therapies.
Application of Muse Cells and exosomes in facial rejuvenation, hair restoration, and skin repair.
Joint repair, tendinopathy management, and sports recovery using advanced regenerative protocols.
Neuroregenerative approaches and chronic pain management through anti-inflammatory strategies.
Regenerative, metabolic, and hormonal peptide profiles, including dilution and administration routes.
Combining cellular therapies with HBOT, PEMF, AI, and advanced diagnostics for comprehensive outcomes.
Strategies for combining cells, exosomes, and peptides in synergistic clinical protocols.
Utilizing ready-to-use consent forms, post-care instructions, and structured clinical follow-up.
Official ISSCA Cellular Therapies & Regenerative Medicine Certification, recognized in 45+ countries and issued exclusively to licensed physicians (MD).
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow
| Registration | Category | Valid Until | Price |
|---|---|---|---|
| Day 1 Conference | Conference Only | Dec 04, 2026 | USD 545 |
| Early Bird Certification | Early bird | Oct 05, 2026 | USD 3,500 |
| Regular Certification | Regular fee | Dec 04, 2026 | USD 4,000 |